BioWorld MedTech

Oct. 8, 2010

FDA clears Calypso system with Dynamic Edge Gating

Calypso Medical Technologies (Seattle) has taken its radiation therapy system a step further by adding the capability to automatically turn off the radiation beam if the tumor moves out of the planned location. (Medical Device Daily) Read More

Newest research shows some surgeries no longer necessary

International report: BioGlue approved in Japan for use in aortic dissections

Washington roundup: FDA to Fresenius: turnover of cassettes not risk reducing

Agreements/contracts: Cook inks pact with HPG for endoscopic technology

MDD's food for med-tech thought

Grants roundup: Wright Medical gets $2.4M for bone graft clinical study

Financings roundup: DEV closes $46M 'D' round; Clear Catheter raises $1.2M

People in the News

Med-Tech Notes

HIT roundup: Quest, HP team up to simplify EHR adoption

Product Briefs

Restructuring roundup: Rosetta Genomics looking to shed $4M in operating costs

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for Feb. 14, 2025.

European VCs optimistic for med-tech exit opportunities in 2025

BioWorld MedTech

To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Feb. 14, 2025

European VCs bullish on med-tech investments in 2025

BioWorld MedTech

European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...

3D illustration of acute myeloid leukemia cells

Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML

BioWorld

Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...